Innovest Global, a diversified industrials company, completed the acquisition of StemVax Therapeutics, a biotechnology company. Financial terms were not disclosed. "We are thrilled to enter this exciting new stage, having recently been approved for a key patent on our core technology. We continue to accelerate developments, seeking to make a difference in the lives of cancer patients with glioblastoma multiforme through our efforts. We have a world class team that will advance our research efforts and future medical technology investments for the benefit of the biomedical communities and our future shareholders," Dwain Irvin, StenVax Founder.